Yes, Grandma's Still Having Sex, And STDs Are Spreading Because of It

Published: August 2025 | Last updated: May 2026

The fastest-growing age group for new sexually transmitted infection diagnoses in the United States is people 55 and older. That fact sits quietly in CDC surveillance data each year, and most readers, including most physicians, never see it surfaced in plain language. Older adults are dating, partnering, and rediscovering intimacy in retirement communities and after long marriages. They are also testing less, using condoms less, and being asked about their sex lives less often than any other adult cohort. The gap between behavior and screening is exactly where infections settle in.

According to the American Medical Association, STI cases among adults 65 and older have more than doubled in the United States over the past decade, with chlamydia roughly tripling, gonorrhea climbing about sixfold, and syphilis up nearly tenfold in that age group. This article walks through what the surveillance data shows, why STIs in older bodies are easy to mistake for ordinary aging, what keeps older adults from getting screened, and how at-home STI test kits fit an age group the clinic system has largely overlooked. (Disclosure: stdrapidtestkits.com sells the at-home STI testing kits referenced in this article. We recommend products based on fit for the reader's concern, not commercial benefit.)

What the Numbers Actually Show

STIs in adults aged 55 and over have been climbing for more than a decade. The CDC's national STI surveillance program tracks reportable infections by age, and the older-adult numbers have moved sharply upward. Between 2010 and 2023, chlamydia cases in the 65-and-older group more than tripled, gonorrhea cases rose roughly sixfold, and syphilis cases climbed nearly tenfold, per AMA clinical commentary summarizing the surveillance data.

Adults over 50 represented a small fraction of new STI cases when surveillance reporting expanded in the 1980s. They no longer do. The trend held through the COVID-19 disruption, with STIs in the 65-and-older group rising nearly 24% during the public health emergency period and HPV-related disease showing one of the largest jumps in that window. The United States recorded roughly a 5% increase in total STI cases between 2020 and 2023, but older adults drove a disproportionate share of that rise.

HIV diagnoses tell a parallel story. In 2022, people aged 50 and older made up 16% of all new HIV diagnoses in the United States, per NIH HIV information. As of the same year, about 54% of people living with HIV in the United States were aged 50 and older, partly because effective treatment has extended life expectancy for people diagnosed decades ago, and partly because new diagnoses in this age group continue. Older adults are also more likely to be diagnosed late, after the infection has already progressed, because routine screening rarely covers them.

The trend is not isolated to the United States. Public-health agencies across Europe, Australia, and parts of Asia report similar patterns, particularly inside institutional care settings. The World Health Organization reports more than one million new curable STI cases per day globally among adults aged 15 to 49, and aging populations face the same transmission dynamics as younger cohorts when screening and protection lapse.

The CDC's annual surveillance reports consistently show the steepest year-over-year percentage increases in age brackets most clinicians never associate with sexual risk. That matters because surveillance shapes screening guidelines, and screening guidelines shape who gets tested. The system built to catch infections early is looking at the wrong age groups. When a 70-year-old with mild urinary discomfort is treated for a urinary tract infection five times in a year without a single sexual-health question, the chlamydia behind those symptoms can keep spreading unnoticed.

Four Myths That Keep Older Adults Unscreened

A handful of beliefs do most of the damage. Each one feels reasonable from inside the lived experience of someone over 60, which is exactly why they persist. The CDC notes that most STIs are asymptomatic in early stages, and the AMA has found that physicians rarely initiate sexual-health conversations with older patients, which means the misconceptions below go unchallenged for years.

Why STIs Get Missed in Older Bodies

Many STIs in older adults present with subtle, easily dismissed symptoms. A burning sensation while urinating gets logged as a urinary tract infection. Genital discomfort or itching is attributed to postmenopausal dryness or incontinence-related skin irritation. Vaginal discharge is shrugged off as ordinary aging. A small sore is assumed to be a friction tear. None of those conclusions are unreasonable on their own. The trouble is that few clinicians follow up with a swab or blood test before moving on.

Most STIs are silent in early stages, which makes symptom-watching a poor screening strategy at any age. Most chlamydia and gonorrhea infections produce no noticeable symptoms in women, and a substantial share are silent in men, per the CDC's STI Treatment Guidelines. Syphilis can sit dormant for years between primary and tertiary stages; left untreated, it can eventually produce neurological and cardiovascular symptoms that resemble dementia or heart disease. HIV often produces flu-like symptoms in the first weeks, then nothing visible for years. The same masking happens with oral and anal exposure: pharyngeal gonorrhea is largely asymptomatic in any age group, and in older adults, mild throat soreness gets folded into the long list of late-life complaints and is never tested.

Aging changes the body in ways that raise risk. After menopause, vaginal tissue tends to thin and produce less natural lubrication (a condition called vaginal atrophy), making microtears during intercourse more likely and giving infections like HIV, gonorrhea, and chlamydia an easier route in. Older immune systems can be less efficient at clearing some infections; HPV that might be cleared by a younger immune response can persist longer, raising long-term cancer risk. Men with prostate-related changes may notice urinary symptoms that mask or mimic gonorrhea and chlamydia.

Medications common in this age group shape the picture further. Erectile-dysfunction drugs like sildenafil do not change how infections transmit, but they increase how often sex happens in an age group where condom use has largely lapsed. More frequent sex paired with near-zero condom habits raises infection rates in a fairly direct way. Diabetes, more prevalent in older adults, can blunt symptoms by changing the body's response to infection. Immunosuppressive medications for autoimmune conditions or transplant management add another layer.

The practical effect: the same chlamydia infection caught at a 23-year-old's annual exam can quietly persist for months in a 73-year-old who is told her symptoms are "just menopause." Untreated chlamydia and gonorrhea raise the risk of pelvic inflammatory disease, urinary complications, and onward transmission. Untreated syphilis can progress over years and eventually affect the heart, brain, and nerves.

Inside Retirement Communities and Long-Term Care

Retirement villages, assisted-living facilities, and skilled nursing homes bring people together by design. Shared meals, social hours, exercise classes, and proximity create the conditions that build emotional bonds. When emotional intimacy grows, physical intimacy often follows. National survey data summarized by the AMA shows that roughly 26% of adults aged 60 to 69 have sex weekly, and about 17% of those 70 and older still do. About 40% of adults aged 65 to 80 are sexually active overall, with roughly two-thirds reporting interest in sex.

The demographics inside these communities shape sexual networks. Women outlive men by several years on average, creating a notable gender skew in most long-term care settings. A man in reasonable health and good spirits may have multiple potential partners. Women who want partnered intimacy may have fewer options and may not know much about a partner's sexual history. Women outnumbering men in these settings is unremarkable on its own; it becomes relevant when one untreated infection has multiple potential onward contacts and condoms are rarely part of the conversation.

Most facilities still have no formal policy on resident sexuality. Few stock condoms in shared spaces. Few train staff to discuss STI risk the way they discuss falls or medication adherence. The AMA's clinical commentary urges physicians to take the lead on safer-sex conversations, screening, and prevention tools, but few facility-level policies reflect that guidance.

Regional surveillance has documented STI case clusters in retirement and assisted-living facilities, with year-over-year increases that outpace several younger age bands. The dynamics mirror dating-app pools in any community: more new partners, less consistent condom use, and less routine testing than the underlying risk warrants. Infections inside care communities often spread for weeks or months before anyone connects the dots. A nurse may notice a small uptick in urinary symptoms on the floor, or a primary-care visit may flag an unexpected positive test, and only then does anyone start asking partner-history questions. The driver is the absence of facility-level policy that anticipates sexual activity at all, combined with a cultural reflex to pretend the issue does not apply.

The Screening Gap: Why No One Brings It Up

The biggest single driver of rising STI rates in older adults is the silence around the topic. Adult children rarely ask their parents about new partners. Nurses rarely ask residents. Primary-care doctors rarely raise the subject during routine visits. The AMA's clinical commentary calls this out directly, urging physicians to take the lead on safer-sex conversations, screening, and prevention tools including HPV vaccination where appropriate.

The reasons are practical: time pressure, an assumption that older patients are not sexually active, and clinician discomfort with the topic. A primary-care visit oriented around chronic disease management leaves few minutes for anything else. The result is a routine in which younger patients get asked about sexual health and older patients do not, even when their actual risk profiles are comparable.

The silence feeds back on itself. Patients do not bring it up because they sense the topic is unwelcome. Providers do not bring it up because patients do not. Screening guidelines for adults over 65 lag because the recorded prevalence looks lower than it actually is. Lower recorded prevalence justifies less screening. Less screening produces lower recorded prevalence. The gap only closes when clinicians start asking the question, and when patients start expecting to be asked.

Many older adults grew up in eras when sex education was either abstinence-only or nonexistent, and were never taught what herpes looks like, how HPV transmits, or that chlamydia can be silent for months. Dating apps like SilverSingles, OurTime, and Match have made it easier than ever to meet a new partner late in life, often without the screening habits younger adults absorb after years of swiping. Many older adults entering a new sexual relationship have not had an STI test in twenty or thirty years. The vocabulary of routine screening, window periods, and asymptomatic carriage came after most of them finished formal education.

Add to this the awkward space around what counts as "real sex." Many older adults grew up understanding intercourse as the only category that mattered, which means oral or manual encounters often do not register as occasions for testing. Herpes spreads skin-to-skin during oral or genital contact. Gonorrhea and syphilis can transmit through oral exposure. Chlamydia is most efficient through unprotected vaginal or anal intercourse, but is far from the only infection at play. The category of "I haven't really had sex" is, for transmission purposes, much narrower than most people assume.

About 40% of people 65 to 80 are sexually active, and nearly two-thirds of older adults are interested in sex.

Talking About It, With Doctors and Partners

For most older adults, the biggest barrier to sexual health is the conversation, not the test itself. Bringing the topic up with a primary-care provider can feel exposing in a way that medication reviews and blood-pressure checks do not. The fastest way through is to script the opening sentence in advance.

A clean opening for your doctor: "I have become sexually active again, and I want to make sure I am healthy. Can you order standard STI screening?" That sentence does the entire job. It signals that you want the test, removes any ambiguity about whether the visit calls for one, and skips the need to share details about partners. A good provider will take it from there. Alternatives that work just as well: "I would like to add an STI panel to my routine bloodwork this year," or "I have a new partner and want a baseline screen." These keep the request routine and skip the longer conversation about whether you "need" testing.

Conversations with partners can feel even higher stakes. The same principle applies: test first, lead with results. "I had a full STI screen last month and everything came back negative. I would like to know your status before we go further." That framing makes the request mutual and grounded in care, not suspicion. It gives a partner the social permission they may have been waiting for.

A few practical points worth raising with a new partner:

• When was the last STI test, and what was tested for? "Full panel" is not specific enough; ask which infections were included.
• Have there been new partners since that test? A result from 18 months ago is not current.
• Are condoms used with other partners? This matters if the relationship is non-monogamous.
• Any history of herpes outbreaks, HPV-related diagnoses, or hepatitis? These are manageable but worth knowing about up front.

If a partner declines to test or refuses to use protection, that tells you something concrete about how they will handle other health decisions that affect you both. Treat it as information you can act on, the same way you would treat a partner's approach to any shared risk.

For people in retirement or assisted-living communities, the same scripts work. The privacy of an at-home test kit can also reduce friction. You can say "I tested at home, here are my results" without having to explain a clinic visit to neighbors or staff.

Testing at Home: Why It Fits Older Lives

Older adults face friction at the clinic that younger adults do not. Mobility limitations, transportation, judgmental waiting rooms, and the sense that sexual-health visits are "for younger patients" can all push testing further down the to-do list. At-home rapid STI test kits remove most of those barriers: flat upfront cost, no clinic copay, no insurance EOB, and no appointment.

Three sample types cover most of what older adults need:

• Blood (fingerstick lateral-flow tests): HIV, syphilis, hepatitis B, hepatitis C, HSV-1, HSV-2. Each has its own window period: HIV antibody tests are most reliable from about 6 weeks (12 weeks for the definitive window), syphilis around 3 to 6 weeks, hepatitis C from about 8 to 11 weeks.
• Genital swab (self-collected): chlamydia, gonorrhea, trichomoniasis (vaginal swab, women only), HPV (vaginal swab, women only). Swab tests detect the infection itself rather than antibodies, so they become accurate within 1 to 2 weeks of exposure.
• Combination kits: bundles screening for 2, 3, 6, 7, 8, or 10 infections at once. These work well when at least 12 weeks have passed since a new partner or known exposure, clearing all relevant antibody windows.

Lateral-flow rapid kits are not the same technology as laboratory NAAT testing, which is the analytical gold standard. They are a strong screening tool that delivers a clear answer in about 15 minutes. A positive result is always worth confirming with a clinic-administered NAAT, both for diagnostic certainty and to start treatment quickly. A negative result outside the relevant window period is informative and reassuring, especially as part of a routine screening habit. The CDC's STI Treatment Guidelines and the NHS both emphasize that screening should be triggered by risk (a new partner, multiple partners, condomless sex with a non-monogamous partner) rather than by symptoms.

Two practical scope notes for older adults specifically. Our trichomoniasis and HPV swabs are validated for vaginal self-collection only; we do not currently sell a male-compatible version of those two tests. Anyone who needs a pharyngeal or rectal swab should plan to see a clinic, since those sample sites are not in scope for any home rapid kit on the market today.

Two prevention tools are easy to overlook in later life. Hepatitis B vaccination is recommended for unvaccinated adults at risk and is a one-time series that protects for decades. HPV vaccination is FDA-approved through age 45 with shared clinical decision-making per ACIP guidance, which means it remains a reasonable conversation with a clinician even after a long gap between sexual partners.

8-in-1 At-Home STD Test Kit (Men and Women)

Complete 8-in-1 STD At-Home Rapid Test Kit

$512.00

Rapid lateral-flow kit screening for 8 common STIs at home with fingerstick blood and self-collected swab samples. Designed for both men and women, private results in about 15 minutes, no clinic visit required.

See the 8-in-1 Kit

A Practical Plan for Staying Protected

Desire does not expire at a certain age. Estrogen levels shift, joints ache, recovery takes longer, but the value of partnered intimacy holds steady well into late life. For many older adults, especially after a divorce, a long marriage, or the loss of a spouse, sexual reconnection is part of rebuilding a sense of self. Sexual freedom in older age depends on the same scaffolding it depends on at any age: honest conversations, regular testing, and protection when status is uncertain.

A practical plan for adults over 50 who are sexually active or considering it again:

1. Get a baseline panel. If you have not been tested for STIs in years, run a full screen: HIV, syphilis, hepatitis B, hepatitis C, chlamydia, gonorrhea, and HSV-2 at minimum. An at-home combination kit covers most of this in one package.
2. Test before new partners. Ask any new partner to do the same. Treat it as a routine step alongside discussing relationship boundaries.
3. Use condoms with new or non-monogamous partners. They reduce risk significantly for most bacterial STIs and HIV. They do not eliminate HSV or HPV risk (those transmit via skin-to-skin contact in areas a condom may not cover), but they still help.
4. Re-test after exposures. If you have had condomless sex with a new or non-monogamous partner, test at the appropriate window: about 12 weeks for antibody-based tests, 1 to 2 weeks for chlamydia and gonorrhea swabs.
5. Discuss vaccination. Hepatitis B vaccination is recommended for unvaccinated adults at risk. HPV vaccination is FDA-approved through age 45 with shared clinical decision-making.
6. Treat findings promptly. Most bacterial STIs (chlamydia, gonorrhea, syphilis, trichomoniasis) are curable with short antibiotic courses when caught early. Viral infections (HIV, herpes, hepatitis B, HPV) have effective long-term management. Knowing your status lets you act on it.

None of this requires reinventing your sex life. It is a small habit on top of an otherwise normal year: a screening test once or twice annually, or before a new partner, plus a condom for new exposures.

6-in-1 Multi-STD Essential Kit

Essential 6-in-1 STD At-Home Rapid Test Kit

$384.00

Compact rapid screening kit covering 6 of the most common STIs in one package. Mix of fingerstick blood and self-swab samples, results in about 15 minutes, fully private at-home use.

See the 6-in-1 Kit

1. American Medical Association. Clinical commentary on rising STI rates among older adults, including the 2010-2023 decade-scale increases (chlamydia tripling, gonorrhea sixfold, syphilis tenfold in the 65-and-older group), the 3% condom-use rate in adults over 60, and the NPAH sexual-activity figures for adults 65-80.
2. U.S. Centers for Disease Control and Prevention. National STI Surveillance Reports and About STIs hub: age-stratified incidence data for chlamydia, gonorrhea, and syphilis; definitions, transmission routes, and asymptomatic-carriage rates for the nine major sexually transmitted infections.
3. U.S. Centers for Disease Control and Prevention. STI Treatment Guidelines: screening recommendations, window periods, asymptomatic-carriage context, and risk-based screening triggers without an upper age limit.
4. U.S. National Institutes of Health. HIV and Older People fact sheet: 16% of new U.S. HIV diagnoses in 2022 were in people aged 50 and older; 54% of people living with HIV were 50 or older as of 2022.
5. World Health Organization. Sexually transmitted infections (STIs) fact sheet: global incidence (more than one million new curable cases per day among adults aged 15 to 49), asymptomatic-carriage rates, and prevention guidance.
6. UK National Health Service. Sexually transmitted infections (STIs): overview of common infections, transmission routes, risk-based screening guidance, and treatment summaries.

Maya Chen

Maya writes plain-English explainers on STI screening, prevention, and at-home testing. Background in epidemiology research at a state public-health department; articles synthesize CDC and peer-reviewed guidance, not personal clinical advice.